Scientific prerequisites and prospects for the use of sildenafil in patients with COVID-19


V.M. Tsvetov (1), A.V. Matveev (2)

1) Federal Center for Cardiovascular Surgery, Chelyabinsk, Russia,; 2) Russian Medical Academy of Continuous Professional Education, Moscow, Russia,
Currently, there are only theoretical prerequisites for using the sildenafil to treat patients with COVID-19. There is no clinical evidence to recommend the use of this drug in real clinical practice to prevent and alleviate symptoms in patients with COVID-19. The use of sildenafil in the treatment of a new coronavirus infection is possible only within the framework of clinical trials.
Keywords: COVID-19, sildenafil

Бионика Медиа